Is Amoxicillin-Clavulanic Acid Dialyzable in Peritoneal Dialysis?
Yes, both amoxicillin and clavulanic acid are dialyzable during peritoneal dialysis, and amoxicillin-clavulanic acid can be removed from circulation by hemodialysis 1. However, the quantity of drugs removed during peritoneal dialysis is substantially lower than during hemodialysis 2.
Dialyzability and Dosing Considerations
Key Pharmacokinetic Properties
Both amoxicillin and clavulanic acid penetrate rapidly into peritoneal fluid. Mean peritoneal fluid levels of amoxicillin reach 84% of serum levels, while clavulanic acid reaches 66% of serum levels 3. The peritoneal levels of both agents decline in parallel to serum levels, with half-lives of approximately 1 hour 3.
Dosing Adjustments for Peritoneal Dialysis
The FDA drug label provides specific guidance for renal impairment but does not distinguish between hemodialysis and peritoneal dialysis 1. For hemodialysis patients, the recommendation is:
- 500 mg/125 mg or 250 mg/125 mg every 24 hours (depending on infection severity)
- Additional dose both during and at the end of dialysis
However, these hemodialysis recommendations should not be directly applied to peritoneal dialysis patients 2.
Critical Distinction: CAPD vs Hemodialysis
The cumulative removal of renally excretable drugs is actually higher in continuous ambulatory peritoneal dialysis (CAPD) patients than in hemodialysis patients between sessions because CAPD is a continuous hemocatharsis procedure 2. Therefore:
- Weekly dosage can be approximately the same in CAPD and hemodialysis patients
- Dosing design for pre-end-stage renal disease patients can be applied to CAPD patients 2
- Supplemental administration after exchanges is generally not necessary in CAPD patients 2
Practical Dosing Approach
For peritoneal dialysis patients requiring amoxicillin-clavulanic acid:
Start with standard renal dosing for GFR <10 mL/min: 500 mg/125 mg or 250 mg/125 mg every 24 hours 1
Do not give supplemental doses after peritoneal dialysis exchanges (unlike hemodialysis) 2
Monitor clinical response closely and adjust based on residual renal function if present 2
Consider that drug clearance is enhanced in automated peritoneal dialysis compared to CAPD 2
Important Caveats
Route of Administration for Peritonitis
When treating CAPD-related peritonitis with antibiotics that bind strongly to proteins, intraperitoneal administration is preferable to intravenous because only unbound drug can transport to peritoneal dialysate 2. However, amoxicillin-clavulanic acid has good peritoneal penetration when given intravenously 3.
Residual Renal Function
Patients with urine output have higher drug clearance than anuric patients 2. If residual renal function becomes impaired in CAPD patients with urine output, decreased drug clearance must be compensated for, potentially requiring weekly hemodialysis in some cases 2.
Resistance Considerations
Recent data show high resistance rates (36-100%) to amoxicillin-clavulanic acid among pathogens causing CAPD-associated peritonitis 4. Gram-positive bacteria (particularly Staphylococcus epidermidis) are the main pathogens and are more sensitive to vancomycin, teicoplanin, and linezolid 4.